Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma

Clinical trial NCT07162012 · RECRUITING

Trial details

NCT number: NCT07162012
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

NK/T-cell Lymphoma Peripheral T-cell Lymphoma (PTCL)DLBCL

Start date: 2025-09-20
Primary completion: 2028-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.